- Q4 2023 Cue Biopharma Inc Earnings Call TranscriptApr 08, 2024$2.04 (+10.27%)Earnings
- Q3 2023 Cue Biopharma Inc Earnings Call and Business Update TranscriptNov 09, 2023$2.08 (-11.32%)Earnings
- Q2 2023 Cue Biopharma Inc Earnings Call TranscriptAug 09, 2023$3.62 (+1.12%)Earnings
- Cue Biopharma Inc To Host Business Update Call TranscriptJun 14, 2023
- Cue Biopharma Inc at Jefferies Healthcare Conference TranscriptJun 09, 2023
- Cue Biopharma Inc at JMP Securities Life Sciences Conference TranscriptMay 15, 2023
- Q4 2022 Cue Biopharma Inc Earnings Call TranscriptMar 21, 2023$3.38 (+9.39%)Earnings
- Q3 2022 Cue Biopharma Inc Earnings Call TranscriptNov 14, 2022$3.25 (+3.50%)Earnings
- Q2 2022 Cue Biopharma Inc Earnings And Business Update Call TranscriptAug 23, 2022
- Cue Biopharma Inc at JMP Securities Life Sciences Conference TranscriptJun 16, 2022
- Cue Biopharma Inc To Host Business Update And Ongoing CUE-101 Clinical Trials Call TranscriptJan 26, 2022
- Q2 2021 Cue Biopharma Inc Earnings Call TranscriptAug 17, 2021$10.32 (+1.57%)Earnings
- Q1 2021 Cue Biopharma Inc Earnings Call TranscriptMay 17, 2021$14 (+2.41%)Earnings
- Q4 2020 Cue Biopharma Inc Earnings Call TranscriptMar 16, 2021$14.82 (-1.92%)Earnings
- Cue Biopharma Inc at Cowen Healthcare Conference (Virtual) TranscriptMar 04, 2021
- Cue Biopharma, Inc. - Special Call TranscriptNov 17, 2020
- Cue Biopharma Inc at Morgan Stanley Global Healthcare Conference (Virtual) TranscriptSep 17, 2020
- Q2 2020 Cue Biopharma Inc Earnings Call TranscriptAug 31, 2020$17.87 (+0.79%)Earnings
- Q1 2020 Cue Biopharma Inc Earnings Call TranscriptMay 19, 2020$27.14 (+2.18%)Earnings
- Q4 2019 Cue Biopharma Inc Earnings Call TranscriptMar 17, 2020$11.41 (-2.14%)Earnings
- Cue Biopharma, Inc. - Special Call TranscriptNov 12, 2019
- Cue Biopharma Inc Investor Business Update TranscriptMay 21, 2019
- Cue Biopharma, Inc. - Special Call TranscriptMar 14, 2019
Q4 2023 Cue Biopharma Inc Earnings Call Transcript
Greetings, and welcome to the Cue Biopharma Investor Update Call. (Operator Instructions) As a reminder, this conference is being recorded. I would now like to turn the conference over to Dan Passeri, Cue Biopharma's Chief Executive Officer. You may begin.
Thank you, and good afternoon, everyone. As a reminder, this presentation and discussion is being recorded and will be available on our website for the next 30 days. Also, please be aware that the slides accompanying today's update may be advanced directly by those listening in on the call and will notify you on what slide we're on throughout this presentation. Joining me on today's call are Dr. Anish Suri, our President and Chief Scientific Officer; Dr. Matteo Levisetti, our Chief Medical Officer; and Kerri-Ann Millar, our Chief Financial Officer.
As shown on slide 2, our presentation and overview may contain some forward-looking statements and any forward-looking statement made during this call represents the company's views only
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |
![](https://static.gurufocus.com/material/money-back-guarantee.png)
![](https://static.gurufocus.com/trust_rating.png)
![](https://static.gurufocus.com/trust.png)